These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 12790691)
1. Current management strategies for coexisting diabetes mellitus and obesity. Scheen AJ Drugs; 2003; 63(12):1165-84. PubMed ID: 12790691 [TBL] [Abstract][Full Text] [Related]
2. Treatment of diabetes in patients with severe obesity. Scheen AJ Biomed Pharmacother; 2000 Mar; 54(2):74-9. PubMed ID: 10759290 [TBL] [Abstract][Full Text] [Related]
3. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ; Bailey CJ Drugs; 2005; 65(3):385-411. PubMed ID: 15669880 [TBL] [Abstract][Full Text] [Related]
5. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat. Scheen AJ; Ernest P Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323 [TBL] [Abstract][Full Text] [Related]
6. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
7. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
8. Drug interactions of clinical importance with antihyperglycaemic agents: an update. Scheen AJ Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007 [TBL] [Abstract][Full Text] [Related]
9. [Obesity and type 2 diabetes]. Rorive M; Letiexhe MR; Scheen AJ; Ziegler O Rev Med Liege; 2005; 60(5-6):374-82. PubMed ID: 16035297 [TBL] [Abstract][Full Text] [Related]
10. The management of the obese diabetic patient. Albu J; Raja-Khan N Prim Care; 2003 Jun; 30(2):465-91. PubMed ID: 14567159 [TBL] [Abstract][Full Text] [Related]
12. Management of blood glucose in type 2 diabetes mellitus. Ripsin CM; Kang H; Urban RJ Am Fam Physician; 2009 Jan; 79(1):29-36. PubMed ID: 19145963 [TBL] [Abstract][Full Text] [Related]
13. The impact of pharmacotherapy on weight management in type 2 diabetes. Hauner H Int J Obes Relat Metab Disord; 1999 Jun; 23 Suppl 7():S12-7. PubMed ID: 10455466 [TBL] [Abstract][Full Text] [Related]
14. Obesity medications and the treatment of type 2 diabetes. Greenway F Diabetes Technol Ther; 1999; 1(3):277-87. PubMed ID: 11475274 [TBL] [Abstract][Full Text] [Related]
16. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus. Strowig SM; Raskin P Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007 [TBL] [Abstract][Full Text] [Related]
17. Recent developments and emerging therapies for type 2 diabetes mellitus. Evans AJ; Krentz AJ Drugs R D; 1999 Aug; 2(2):75-94. PubMed ID: 10820647 [TBL] [Abstract][Full Text] [Related]
18. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM). Wolffenbuttel BH; van Haeften TW Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759 [TBL] [Abstract][Full Text] [Related]
19. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus). Cheah JS Singapore Med J; 1998 Aug; 39(8):380-4. PubMed ID: 9844503 [TBL] [Abstract][Full Text] [Related]